SKIN · SkinHealth Systems Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Active install base | 36,419 | Q1 2026 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | $8.5M | Q1 2026 | — |
| Adjusted EBITDA margin non-GAAP | 13.1% | Q1 2026 | — |
|
|
|||
| Adjusted gross margin non-GAAP | 72.2% | Q1 2026 | — |
|
|
|||
| Adjusted gross profit non-GAAP | $46.9M | Q1 2026 | — |
|
|
|||
| Adjusted operating expenses non-GAAP | $38.4M | Q1 2026 | — |
|
|
|||
| Total delivery systems sold | 746 | Q1 2026 | — |
|
|
|||
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SKIN
this stock
SkinHealth Systems Inc.
|
$83.40M | -53.7% | -10.0% | — | 6.8% |
|
PG
PROCTER & GAMBLE Co
|
$346.68B | +2.7% | +0.3% | 21.8 | 1.0% |
|
UL
Unilever PLC
|
$142.12B | +2.7% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$74.20B | +19.0% | +1.7% | 35.9 | 2.1% |
|
KVUE
Kenvue Inc.
|
$38.00B | +16.0% | -2.1% | 23.6 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SKIN | -14.8% | -7.1% | -55.6% | -7.1% | -53.7% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | -12.4% | -4.8% | -61.9% | -4.8% | -60.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.